Filtrar por Last updated date SelectDespués deAntes deFrom - To Fecha Fecha de final Esta semana Este mes la semana pasada El mes pasado Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Deje este campo en blanco Filter Resultados (3794) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Deje este campo en blanco Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 3-5 December 2019 6 Diciembre 2019 Press release Veterinary Medicines EMA update on metformin diabetes medicines 6 Diciembre 2019 Press release Human Referrals Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 November 2019 29 Noviembre 2019 News Human Pharmacovigilance Quality of medicines Referrals ‘Regulatory science to 2025’: live broadcast of post-consultation workshop on veterinary medicines 28 Noviembre 2019 News Corporate Dutch authorities hand over final building to EMA in Amsterdam 15 Noviembre 2019 News Corporate Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 November 2019 (updated) 15 Noviembre 2019 News Human Data on medicines EMA confirms Xeljanz to be used with caution in patients at high risk of blood clots 15 Noviembre 2019 Press release Human Medicines Pharmacovigilance Referrals Measures to minimise risk of serious side effects of multiple sclerosis medicine Lemtrada 15 Noviembre 2019 Press release Human Medicines Pharmacovigilance Referrals First vaccine to protect against Ebola 14 Noviembre 2019 Press release Human Medicines Regulators’ advice can make a difference for faster patient access to highly innovative therapies 12 Noviembre 2019 News Corporate 1 … 92 93 94 95 96 Page 96 of 380 97 98 99 100 … 380
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 3-5 December 2019 6 Diciembre 2019 Press release Veterinary Medicines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 November 2019 29 Noviembre 2019 News Human Pharmacovigilance Quality of medicines Referrals
‘Regulatory science to 2025’: live broadcast of post-consultation workshop on veterinary medicines 28 Noviembre 2019 News Corporate
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 November 2019 (updated) 15 Noviembre 2019 News Human Data on medicines
EMA confirms Xeljanz to be used with caution in patients at high risk of blood clots 15 Noviembre 2019 Press release Human Medicines Pharmacovigilance Referrals
Measures to minimise risk of serious side effects of multiple sclerosis medicine Lemtrada 15 Noviembre 2019 Press release Human Medicines Pharmacovigilance Referrals
Regulators’ advice can make a difference for faster patient access to highly innovative therapies 12 Noviembre 2019 News Corporate